WILMINGTON, N.C.–(BUSINESS WIRE)–Pharmaceutical Product Development, LLC (PPD)
won multiple honors in the annual PharmaTimes Clinical Researcher of the
Year competitions, with 16 PPD clinical research professionals
recognized by industry peers for their expertise in the enterprise of
drug development.
PPD clinical researchers won two gold, four silver and three bronze
awards at the PharmaTimes
Clinical Researcher of the Year – International competition finale
in London. They were recognized in categories including Aspiring
Clinical Researcher, Clinical Research Associate, In-House Clinical
Researcher and Clinical Research Team. At the PharmaTimes
Clinical Researcher of the Year – The Americas competition finale in
Boston, a PPD clinical research associate (CRA) earned silver in the
Experienced CRA category.
“PPD’s clinical researchers embody the utmost expertise and
professionalism to achieve this industry recognition,” said Roger
Newbery, senior vice president of integrated monitoring and investigator
services for PPD. “We congratulate them on this honor and appreciate the
talent, success and dedication our clinical researchers bring to all of
our clients and their research programs.”
PPD prepares CRAs for success with its acclaimed Clinical Foundation
Program and PPD’s CRA Academy, which reflect the company’s strategic
emphasis on recruiting, training and retaining industry-leading talent
for customers’ important research programs. PPD’s award-winning programs
for employee development have earned it recognition for eight
consecutive years on Training
magazine’s Training Top 125 list of companies excelling in
employee learning and development. PPD has been named for two
consecutive years to Forbes
magazine’s list of America’s Best Large Employers.
The PharmaTimes competition was created in 1999 to provide clinical
research professionals with the opportunity to benchmark their
professional skills against their peers in a program of competency-based
exercises developed through cross-industry collaboration. Both
competitions featured a demanding, yearlong, three-part series of tests,
including real-life challenges judged by industry leaders.
About PPD
PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and lifecycle
management services. Our clients and partners include pharmaceutical,
biotechnology, medical device, academic and government organizations.
With offices in 48 countries and more than 21,000 professionals
worldwide, PPD applies innovative technologies, therapeutic expertise
and a firm commitment to quality to help clients and partners bend the
cost and time curve of drug development and optimize value in delivering
life-changing therapies to improve health. For more information, visit www.ppdi.com.
Contacts
Media:
Holly Devine
+1 919 456 6389
holly.devine@ppdi.com
Investors:
Nate Speicher
+1 910 558 6783
nate.speicher@ppdi.com